ClinicalTrials.gov
public full text
Public Domain
Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients
Participants to the study will be assigned to 7 cohorts according to the stage of disease and planned antitumor treatment at time of study entry. In all patients, 12 ml of blood sample will be collected in EDTA tube for analysis of biological biomarkers in different time points.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Validation of the Prostate Cancer Assay - Beta+Pivotal#909018
- Data Resource Profile: Prostate cancer data from Clinical Practice Research Datalink linked hospital records, mortality data and cancer registry standardized to the Observational Medical Outcomes Partnership common data model (CPRD-PCa-OMOP)#168475
- Predictors of BCR After RARP for Localized Prostate Cancer: A Retrospective Analysis#828924
- miRNA Panel for PCa Diagnosis#830765
- 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients#849758
Record · ID 828628
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive